Results 51 to 60 of about 6,107 (224)
Terlipressin-Related Acute Myocardial Infarction: A Case Report and Literature Review
Kaohsiung Journal of Medical Sciences, 2004 Acute ST-segment elevation myocardial infarction after the administration of terlipressin in patients with hemorrhagic esophageal varices is a rare but life-threatening complication.
Min-Yi Lee +7 more
doaj +1 more source
The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
Kidney360, 2023 Key Points Hepatorenal syndrome type 1 (HRS-1) is an often fatal, but potentially reversible, kidney failure in patients with decompensated cirrhosis. Treatment with terlipressin in patients with HRS-1 is associated with a reduction in the need for RRT ...
J. Velez +8 more
semanticscholar +1 more source
Artificial Organs, EarlyView.The therapy with PAP using BR‐350 resulted in a significant decrease of bilirubin concentrations. The median relative reduction of bilirubin was comparable between PAP and OPAL (47% vs. 40%, p = 0.29). The crossover comparison between the single session of PAP using BR‐350 and OPAL revealed similar relative reduction rates of bilirubin.
Justa Friebus‐Kardash +8 more
wiley +1 more source
Role of RIPK1/RIPK3/MLKL signalling pathway in sepsis‐associated acute kidney injury
Experimental Physiology, EarlyView.Abstract Sepsis‐associated acute kidney injury (SA‐AKI) is a common clinical syndrome in critically ill patients, and its high mortality rate is closely related to complex pathological mechanisms. Existing studies have shown that the pathophysiological process of SA‐AKI involves complex multi‐mechanism interactions, including an uncontrolled systemic ...
Huijun Yin, Jingyi Wang, Huirong Han
wiley +1 more source
Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome [PDF]
Journal of Clinical and Diagnostic Research, 2018 Hepatorenal Syndrome (HRS) is a potentially fatal complication of hepatic failure and portal hypertension. Among the various treatments available including octreotide, midodrine and albumin, the current standard of care for stable patients is ...
Aneesh Basheer +3 more
doaj +1 more source
Management Strategies for Refractory Esophageal Varices
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Refractory esophageal varices that are difficult to control or unresponsive to endoscopic treatment remain a major clinical challenge in the management of portal hypertension. This review provides a comprehensive overview of treatment strategies for these cases, along with a comparative analysis of the American Association for the Study of ...
Keita Maki, Hiroaki Haga, Yoshiyuki Ueno
wiley +1 more source
The Concise Guide to PHARMACOLOGY 2025/26: G protein‐coupled receptors
British Journal of Pharmacology, Volume 182, Issue S1, Page S24-S151, December 2025.The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander +206 more
wiley +1 more source
Clinical and Translational Gastroenterology, 2023 INTRODUCTION: Evidence on the comparison of treatments for hepatorenal syndrome-acute kidney injury (HRS-AKI) in a US population is limited. An indirect comparison of terlipressin plus albumin vs midodrine and octreotide plus albumin (MO) may provide ...
S. Gonzalez +5 more
semanticscholar +1 more source
Short-term vasoactive agent treatment driven by physicians’ preference in acute esophageal variceal bleeding in a tertiary center [PDF]
PeerJ, 2019 Background Vasoactive drugs are frequently used in combination with endoscopic variceal ligation (EVL) in treatment of acute esophageal variceal bleeding (EVB).
Yoen Young Chuah +8 more
doaj +2 more sources
The FASEB Journal, Volume 39, Issue 17, 15 September 2025.The study involved patients who experienced acute kidney injury (AKI) following liver transplantation at the Third Affiliated Hospital of Sun Yat‐sen University from January 2015 to February 2023. Patients were categorized into CKD and non‐CKD groups based on their progression to chronic kidney disease (CKD) 3 months post‐surgery.
Liping Li +9 more
wiley +1 more source